Frank E. Thomas, CFO, COO, Interim CEO at AMAG PHARMACEUTICALS INC. (AMAG), bought 500 shares at $19.10 ($10K) on 2012-01-03, disclosed to the SEC on 2012-01-04.
Scheduled purchase ($10k) by CFO, COO, Interim CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ORTX | BUY | 2022-04-04 | $8K | — | Filing → |
| AMAG | SELL | 2015-08-07 | $1.0M | — | Filing → |
| AMAG | SELL | 2015-06-08 | $1.4M | — | Filing → |